Cleared Traditional

NexPort™ Trocar System (TS211001) (K232042) - FDA 510(k) Clearance

Also marketed or referenced as:
NexPort™ Trocar System (TS211002) NexPort™ Trocar System (TS211003) NexPort™ Trocar System (TS211010) NexPort™ Trocar System (TS211011) NexPort™ Trocar System (TS211012) NexPort™ Trocar System (TS221001) NexPort™ Trocar System (TS221002) NexPort™ Trocar System (TS221003) NexPort™ Trocar System (TS221010) NexPort™ Trocar System (TS221011) NexPort™ Trocar System (TS221012) NexPort™ Trocar System (TS221020) NexPort™ Trocar System (TS221021)

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K232042 · Mediconcepts Technology (Shenzhen) Company Limited · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2023
Decision
102d
Days
Class 2
Risk

K232042 is an FDA 510(k) clearance for the NexPort™ Trocar System (TS211001). Classified as Laparoscope, General & Plastic Surgery (product code GCJ), Class II - Special Controls.

Submitted by Mediconcepts Technology (Shenzhen) Company Limited (Shenzhen, CN). The FDA issued a Cleared decision on October 20, 2023 after a review of 102 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 876.1500 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Mediconcepts Technology (Shenzhen) Company Limited devices

Submission Details

510(k) Number K232042 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 10, 2023
Decision Date October 20, 2023
Days to Decision 102 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
13d faster than avg
Panel avg: 115d · This submission: 102d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GCJ Laparoscope, General & Plastic Surgery
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1500
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GCJ Laparoscope, General & Plastic Surgery

All 438
Devices cleared under the same product code (GCJ) and FDA review panel - the closest regulatory comparables to K232042.
CuratOR EX3242-FD
K231066 · Eizo Corporation · Dec 2023
Disposable Abdominal Trocars (Bladed Trocars, Bladeless Trocars, Optical Trocars)
K232866 · Jiangsu Channel Medical Device Co., Ltd. · Nov 2023
Inzii Ripstop Redeployable Retrieval System
K232880 · Applied Medical Resources Corporation · Nov 2023
Laparoscope (4KA0, 4KA0R, 4KA30, 4KA30R, 4KA45, 4KA45R)
K231725 · Hunan Endoso Life Technology Co., Ltd. · Oct 2023
REGER Nebulizer Irrigation Cannula
K231622 · Reger Medizintechnik, GmbH · Sep 2023
Guardenia (GAR-1)
K232701 · Advanced Surgical Concepts · Sep 2023